CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
CP950 OTE Sound processordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03613909
NCT03613909N/ACompleted
CompareCT.gov

Acceptance of the CP950 Sound Processor With Experienced CP810/CP910/CP920 BTE Sound Processor Users

Cochlear·interventional·Posted Aug 3, 2018·Updated Sep 28, 2023

In Brief

A clinical study evaluating CP950 OTE Sound processor for Hearing Loss, Sensorineural. Completed, enrolled 23 participants.

Detailed Summary

Acceptance of CP950 sound processor with experienced CP810/CP910/CP920 BTE sound processor users.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Sensorineural
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 3, 2018
Enrollment StartNov 1, 2015
Primary CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 7.9 years ago

Interventions

CP950 OTE Sound processordevice

CP950 is Off The Ear (OTE) Cochlear Implant Sound Processor